Rivkin Anna
SEC insider (Form 3/4/5 filer). CIK 0002035647. Chief Business Officer at Foghorn Therapeutics Inc. (FHTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 30, 2026. Located in WATERTOWN, MA.
Companies Rivkin Anna has filed insider reports for
- Foghorn Therapeutics Inc. (FHTX): Officer, Chief Business Officer
Rivkin Anna
CIK: 0002035647
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FHTX
Foghorn Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 30, 2026FHTX
Foghorn Therapeutics Inc.
AwardDirectStock option (right to buy)
165K shares at avg. $5.71- - Jan 22, 2025FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Option (right to buy)
50K shares at avg. $4.37- - Sep 3, 2024FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Options (Right to buy)
190K shares at avg. $7.85-
1-3 of 3 transactions